These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1392125)

  • 21. Demonstration of interleukin 8 and autoantibodies to interleukin 8 in the serum of patients with systemic sclerosis and related disorders.
    Reitamo S; Remitz A; Varga J; Ceska M; Effenberger F; Jimenez S; Uitto J
    Arch Dermatol; 1993 Feb; 129(2):189-93. PubMed ID: 8434976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell surface expression of lysosome-associated membrane proteins (LAMPs) in scleroderma: relationship of lamp2 to disease duration, anti-Sc170 antibodies, serum interleukin-8, and soluble interleukin-2 receptor levels.
    Holcombe RF; Baethge BA; Stewart RM; Betzing K; Hall VC; Fukuda M; Wolf RE
    Clin Immunol Immunopathol; 1993 Apr; 67(1):31-9. PubMed ID: 8443983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum levels of soluble interleukin-2 receptor--a possible index of disease prognosis in systemic sclerosis.
    Lis A; Brzezińska-Wcisło L; Rubisz-Brzezińska J; Kulawik I
    Clin Exp Dermatol; 1997 Jan; 22(1):60-1. PubMed ID: 9330064
    [No Abstract]   [Full Text] [Related]  

  • 24. [The different clinical variants of scleroderma in diabetics].
    Khamaganova IV
    Ter Arkh; 1989; 61(10):70-3. PubMed ID: 2609276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Type III procollagen N-terminal propeptide, soluble interleukin-2 receptor, and von Willebrand factor in systemic sclerosis.
    Lee YJ; Shin KC; Kang SW; Lee EB; Kim HA; Song YW
    Clin Exp Rheumatol; 2001; 19(1):69-74. PubMed ID: 11247328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Soluble receptors of cytokines in sera of patients with systemic sclerosis--clinical correlation].
    Lis AD; Brzezińska-Wcisło LA
    Wiad Lek; 2003; 56(11-12):532-6. PubMed ID: 15058159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-phosphatidylserine-prothrombin complex antibodies in patients with localized scleroderma.
    Hasegawa M; Fujimoto M; Hayakawa I; Matsushita T; Nishijima C; Yamazaki M; Takehara K; Sato S
    Clin Exp Rheumatol; 2006; 24(1):19-24. PubMed ID: 16539814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum concentration of procollagen type I carboxyterminal propeptide in localized scleroderma.
    Kikuchi K; Sato S; Kadono T; Ihn H; Takehara K
    Arch Dermatol; 1994 Oct; 130(10):1269-72. PubMed ID: 7944508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated serum levels of soluble interleukin 2 receptor, interleukin 2 and neopterin in diffuse and limited scleroderma: effects of chlorambucil.
    Clements PJ; Peter JB; Agopian MS; Telian NS; Furst DE
    J Rheumatol; 1990 Jul; 17(7):908-10. PubMed ID: 2213757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum copper and caeruloplasmin in ankylosing spondylitis, systemic sclerosis, and morphea.
    Jayson MI; Davis P; Whicher JT; Walters G
    Ann Rheum Dis; 1975 Oct; 35(5):443-5. PubMed ID: 1234411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Androgens in post-menopausal patients with systemic sclerosis.
    Perković D; Martinović Kaliterna D; Jurišić Z; Lalovac M; Radić M
    Rheumatology (Oxford); 2015 Apr; 54(4):744-6. PubMed ID: 25524921
    [No Abstract]   [Full Text] [Related]  

  • 32. Duration of Raynaud's phenomenon is negatively correlated with serum levels of interleukin 10 (IL-10), soluble receptor of interleukin 2 (sIL2R), and sFas in systemic sclerosis patients.
    Dziankowska-Bartkowiak B; Zalewska A; Sysa-Jedrzejowska A
    Med Sci Monit; 2004 May; 10(5):CR202-8. PubMed ID: 15114270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The interleukin-1, interleukin-2, interleukin-6 and tumour necrosis factor alpha serological levels in localised and systemic sclerosis.
    Alecu M; Geleriu L; Coman G; Gălăţescu L
    Rom J Intern Med; 1998; 36(3-4):251-9. PubMed ID: 10822522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated plasma histamine levels in systemic sclerosis (scleroderma).
    Falanga V; Soter NA; Altman RD; Kerdel FA
    Arch Dermatol; 1990 Mar; 126(3):336-8. PubMed ID: 2310207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical significance of soluble CD31 in patients with systemic sclerosis (SSc): association with limited cutaneous SSc.
    Sato S; Komura K; Hasegawa M; Fujimoto M; Takehara K
    J Rheumatol; 2001 Nov; 28(11):2460-5. PubMed ID: 11708419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and laboratory features of systemic sclerosis complicated with localized scleroderma.
    Toki S; Motegi S; Yamada K; Uchiyama A; Kanai S; Yamanaka M; Ishikawa O
    J Dermatol; 2015 Mar; 42(3):283-7. PubMed ID: 25582037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Systemic sclerosis and scleroderma circumscripta--disturbances of selected serum parameters which are responsible for vascular changes and CD34 expression in involved skin].
    Dziankowska-Bartkowiak B; Zebrowska A; Wagrowska-Danielewicz M; Kobos J; Waszczykowska E
    Przegl Lek; 2009; 66(12):1040-5. PubMed ID: 20514902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hemostasis in patients with systemic skin diseases].
    Dovzhanskiĭ SI; Gerasimova MV; Rumiantseva EV
    Vestn Dermatol Venerol; 1990; (10):37-9. PubMed ID: 2278192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased levels of circulating intercellular adhesion molecule-1 in patients with systemic sclerosis.
    Kiener H; Graninger W; Machold K; Aringer M; Graninger WB
    Clin Exp Rheumatol; 1994; 12(5):483-7. PubMed ID: 7842528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-agalactosyl immunoglobulin G antibodies in localized scleroderma.
    Mimra Y; Ihn H; Jinnin M; Asano Y; Yamane K; Yazawa N; Tamaki K
    Int J Dermatol; 2005 Oct; 44(10):817-20. PubMed ID: 16207181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.